Vanguard Group Inc Repligen Corp Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Repligen Corp stock. As of the latest transaction made, Vanguard Group Inc holds 5,101,090 shares of RGEN stock, worth $804 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,101,090
Previous 5,044,367 1.12%
Holding current value
$804 Million
Previous $751 Million 2.19%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$123.41 - $160.92 $7 Million - $9.13 Million
56,723 Added 1.12%
5,101,090 $734 Million
Q3 2024

Nov 13, 2024
SELL
$119.79 - $167.35 $2.64 Million - $3.68 Million
-22,002 Reduced 0.43%
5,044,367 $751 Million
Q2 2024

Aug 13, 2024
SELL
$120.0 - $182.95 $4.04 Million - $6.16 Million
-33,644 Reduced 0.66%
5,066,369 $639 Million
Q1 2024

May 10, 2024
BUY
$170.78 - $208.42 $3.71 Million - $4.53 Million
21,719 Added 0.43%
5,100,013 $938 Million
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $3.81 Million - $6.19 Million
33,404 Added 0.66%
5,078,294 $913 Million
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $1.6 Million - $2.03 Million
-11,508 Reduced 0.23%
5,044,890 $802 Million
Q2 2023

Aug 14, 2023
SELL
$138.42 - $180.31 $3.53 Million - $4.6 Million
-25,521 Reduced 0.5%
5,056,398 $715 Million
Q1 2023

Jul 14, 2023
BUY
$154.26 - $198.1 $3,702 - $4,754
24 Added 0.0%
5,081,919 $856 Million
Q1 2023

May 15, 2023
SELL
$154.26 - $198.1 $19 Million - $24.4 Million
-123,260 Reduced 2.37%
5,081,895 $856 Million
Q4 2022

Feb 10, 2023
BUY
$162.42 - $220.56 $12.4 Million - $16.8 Million
76,271 Added 1.49%
5,205,155 $881 Million
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $4.01 Million - $6.4 Million
24,998 Added 0.49%
5,128,884 $960 Million
Q2 2022

Aug 12, 2022
BUY
$140.68 - $188.02 $29.9 Million - $39.9 Million
212,282 Added 4.34%
5,103,886 $829 Million
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $3.41 Million - $5.46 Million
-21,165 Reduced 0.43%
4,891,604 $920 Million
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $10.3 Million - $12.6 Million
41,509 Added 0.85%
4,912,769 $1.3 Billion
Q3 2021

Nov 12, 2021
SELL
$194.77 - $324.21 $4.44 Million - $7.38 Million
-22,771 Reduced 0.47%
4,871,260 $1.41 Billion
Q2 2021

Aug 13, 2021
BUY
$165.87 - $220.95 $812 Million - $1.08 Billion
4,894,031 New
4,894,031 $977 Million

Others Institutions Holding RGEN

# of Institutions
482
Shares Held
56.3M
Call Options Held
251K
Put Options Held
458K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.75B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email